360 Financial’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

360 Financial’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-78,213	Closed	-$15.7M	–	88
2026 Q1	$15.7M	Buy	78,213 +6,128	+9%	+$1.27M	4.73%	7
2025 Q4	$14.9M	Buy	+72,085	New	+$14.4M	4.5%	7
2020 Q3	–	Sell	-32,342	Closed	-$5.59M	–	72
2020 Q2	$5.59M	Buy	+32,342	New	+$5.08M	4.64%	7

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

360 Financial's FBT Position: Q2 2026 in Review

360 Financial sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 78,213 shares — an estimated $15.7M sold.

360 Financial first reported a position in FBT in Q2 2020 and held it in 3 quarters. The position peaked at $15.7M in Q1 2026. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

360 Financial reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
360 Financial sold 78,213 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $15.7M.
360 Financial first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and held it in 3 quarters.
360 Financial's First Trust NYSE Arca Biotechnology Index Fund position peaked at $15.7M in Q1 2026.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on 360 Financial's 13F filing for Q2 2026, filed 11 Aug 2026.